Use of systemic Janus kinase inhibitors for dermatologic indications in the elderly: A retrospective study of 67 cases

被引:1
作者
Hren, M. Grace [1 ]
Khattri, Saakshi [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA
关键词
DOUBLE-BLIND; ADOLESCENTS; PLACEBO; ADULTS;
D O I
10.1016/j.jaad.2023.11.055
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:816 / 819
页数:4
相关论文
共 5 条
[1]   Advances in treating psoriasis in the elderly with small molecule inhibitors [J].
Cline, Abigail ;
Cardwell, Leah A. ;
Feldman, Steven R. .
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (18) :1965-1973
[2]   Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double- blind, randomised controlled phase 3 trials [J].
Guttman-Yassky, Emma ;
Teixeira, Henrique D. ;
Simpson, Eric L. ;
Papp, Kim A. ;
Pangan, Aileen L. ;
Blauvelt, Andrew ;
Thaci, Diamant ;
Chu, Chia-Yu ;
Hong, H. Chih-Ho ;
Katoh, Norito ;
Paller, Amy S. ;
Calimlim, Brian ;
Gu, Yihua ;
Hu, Xiaofei ;
Liu, Meng ;
Yang, Yang ;
Liu, John ;
Tenorio, Allan R. ;
Chu, Alvina D. ;
Irvine, Alan D. .
LANCET, 2021, 397 (10290) :2151-2168
[3]   JAK-inhibitors in dermatology - small molecules, big impact? Overview of the mechanism of action, previous study results and potential adverse effects [J].
Klein, Benjamin ;
Treudler, Regina ;
Simon, Jan C. .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (01) :19-24
[4]   Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program [J].
Simpson, Eric L. ;
Silverberg, Jonathan I. ;
Nosbaum, Audrey ;
Winthrop, Kevin L. ;
Guttman-Yassky, Emma ;
Hoffmeister, Karin M. ;
Egeberg, Alexander ;
Valdez, Hernan ;
Zhang, Min ;
Farooqui, Saleem A. ;
Romero, William ;
Thorpe, Andrew J. ;
Rojo, Ricardo ;
Johnson, Susan .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (05) :693-707
[5]  
Simpson EL, 2020, LANCET, V396, P255, DOI 10.1016/S0140-6736(20)30732-7